Abstract:BACKGROUND:Breast cancer ranks No. 1 in women cancer incidence, while triple negative breast cancer (TNBC) is the most aggressive and the worst prognostic subtype in all breast cancer subtypes. Compared with estrogen receptor alpha positive breast cancer, which could be well controlled by endocrine therapy, TNBC is lack of mature molecular targets for medical therapy. Thus, it is urgent and necessary to discovery the carcinogenic mechanism and potential therapeutic targets for TNBC. Recent studies reveal that Hippo/YAP signaling is an important mediator for TNBC progression. Our current study investigates the role of RING finger protein RNF181 in modulation Hippo/YAP signaling.METHODS:YAP and RN181 protein level were measured by western blot, while the Hippo classical target genes were measured by real-time PCR. WST1 assay were used to measure cell proliferation, the trans-well and wound healing were used to measure the cell migration and invasion capacity. Protein stability and ubiquitin assay were used to detect the YAP protein ubiquitin and stability. The immuno-precipitation assays were used to detect the protein interactions. Immuno-staining was used to detect the protein localization of YAP and RNF181, while the ubiquitin-based immuno-precipitation assays were used to detect the specific ubiquitination manner of YAP.RESULTS:Our current study identified a novel modulator-RNF181 as a positive mediator for Hippo/YAP signaling activation in TNBC. RNF181 depletion significantly inhibited TNBC cell migration, invasion and proliferation, which effect could be rescued by YAP overexpression. RNF181 depletion decreased YAP protein level and Hippo signaling target genes, such as CTGF and CYR61, in TNBC cell lines. Immuno-precipitation assay showed that RNF181 interact with YAP and promoted YAP stability by inhibition K48-linked poly-ubiquitination of YAP in TNBC cells. Besides, public available data showed that RNF181 is elevated in breast cancer and related to poor prognosis in TNBC patients.CONCLUSION:Our study provides evidence to establish a non-proteolytic mechanism in modulating Hippo signaling in breast cancer. RNF181 could be an interesting marker for triple negative breast cancer prognostics and therapeutics.

The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation

Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice

The Tumor Suppressor NF2 Modulates TEAD4 Stability and Activity in Hippo Signaling Via Direct Interaction

YAP-TEAD and HNF 4 α repress reciprocally to regulate hepatocarcinogenesis Running title : Hippo signaling and HNF 4 α in hepatoma

TEAD Mediates YAP-dependent Gene Induction and Growth Control

The direct interaction with transcriptional factor TEAD4 implied a straightforward regulation mechanism of tumor suppressor NF2

Integration of Hippo Signalling and the Unfolded Protein Response to Restrain Liver Overgrowth and Tumorigenesis

Targeting the Hippo pathway in cancers via ubiquitination dependent TEAD degradation

TEAD4 Induced Positive Feedback Activation of E2R/YAP1 Axis and Promoted Epithelial-mesenchymal Transition through Up-regulating TWIST1 Directly in HCC

Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma.

Tea domain transcription factor TEAD4 mitigates TGF- signaling and hepatocellular carcinoma progression independently of YAP

Tead Transcription Factors Mediate the Function of Taz in Cell Growth and Epithelial-Mesenchymal Transition

Increased Tead4 Expression and Nuclear Localization in Colorectal Cancer Promote Epithelial-Mesenchymal Transition and Metastasis in A Yap-Independent Manner

YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma

A Regulation Loop between YAP and NR4A1 Balances Cell Proliferation and Apoptosis

TEAD4 promotes colorectal tumorigenesis via transcriptionally targeting YAP1

Regulation of Hippo Signaling and Triple Negative Breast Cancer Progression by an Ubiquitin Ligase RNF187

RNF181 Modulates Hippo Signaling and Triple Negative Breast Cancer Progression

RNF166 promotes colorectal cancer progression by recognizing and destabilizing poly-ADP-ribosylated angiomotins

RNF149 Promotes HCC Progression Through Its E3 Ubiquitin Ligase Activity.

Data from A TNFR2–hnRNPK Axis Promotes Primary Liver Cancer Development Via Activation of YAP Signaling in Hepatic Progenitor Cells